Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_assertion type Assertion NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_head.
- NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_assertion description "[Oncolytic measles virus (MV) encoding the human thyroidal sodium iodide symporter (MV-NIS) has proved to be safe after intraperitoneal or intravenous administration in patients with ovarian cancer or multiple myeloma, respectively, but it has not yet been administered through intratumoral injection in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_provenance.
- NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_assertion evidence source_evidence_literature NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_provenance.
- NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_assertion SIO_000772 22235810 NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_provenance.
- NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_assertion wasDerivedFrom befree-2016 NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_provenance.
- NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_assertion wasGeneratedBy ECO_0000203 NP952406.RANZq2q5PeADfttmIW5kC8Ab1Y3SUI7ViMHUTl6z3NibM130_provenance.